REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/10/2026
Back to search
Official data from USPTO
HEMO XR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
07/10/2026
Trademark type
Word
Nice classes
5
Filing date
11/01/2004
Registration date
07/10/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2017
Last transaction
07/10/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2005-10-00
First use in commerce
2005-10-00
Drawing code
4
Owner type
03
Owner location
Santa Fe, CA, US
Examiner
SINGH, TEJBIR
Law office
L60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Blaine Laboratories, Inc.
Representatives
Kirk M. Hartung MCKEE, VOORHEES & SEASE, PLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
TOPICAL BLOOD STOPPING AGENT FOR EXTERNAL USE
Publications
History of USPTO decisions and trademark events.
46 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/19/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/19/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/19/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/19/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
07/10/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/10/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/23/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/23/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/23/2013
E815
TEAS SECTION 8 & 15 RECEIVED
07/10/2013
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
08/16/2008
PLGL
ASSIGNED TO PARALEGAL
08/06/2008
ES7R
TEAS SECTION 7 REQUEST RECEIVED
07/03/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
07/10/2007
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
05/01/2007
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/30/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/26/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/26/2007
ALIE
ASSIGNED TO LIE
04/26/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/26/2007
GNFR
FINAL REFUSAL E-MAILED
03/01/2007
CNFR
SU - FINAL REFUSAL - WRITTEN
03/01/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/13/2007
PETG
PETITION TO REVIVE-GRANTED
02/13/2007
PROA
TEAS PETITION TO REVIVE RECEIVED
02/13/2007
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
02/08/2007
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
02/08/2007
GNRT
NON-FINAL ACTION E-MAILED
06/21/2006
CNRT
SU - NON-FINAL ACTION - WRITTEN
06/21/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/17/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/17/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/17/2006
GNRT
NON-FINAL ACTION E-MAILED
05/11/2006
CNRT
SU - NON-FINAL ACTION - WRITTEN
05/11/2006
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/29/2006
IUAF
USE AMENDMENT FILED
04/12/2006
EISU
TEAS STATEMENT OF USE RECEIVED
04/12/2006
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
01/03/2006
PUBO
PUBLISHED FOR OPPOSITION
10/11/2005
NPUB
NOTICE OF PUBLICATION
09/21/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/23/2005
ALIE
ASSIGNED TO LIE
06/17/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/13/2005
DOCK
ASSIGNED TO EXAMINER
06/06/2005
NWAP
NEW APPLICATION ENTERED
11/08/2004
Continuous trademark protection
Get notified about every new filing that threatens HEMO XR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.